Rigel Pharmaceuticals (RIGL)
(Delayed Data from NSDQ)
$12.90 USD
-0.31 (-2.35%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $12.95 +0.05 (0.39%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | 0.01 |
EPS Last Quarter | -0.06 |
Last EPS Surprise | 83.78% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.72 |
Next Year | 0.37 |
EPS (TTM) | -0.86 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 40.69M | 45.95M | 151.60M | 191.37M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 43.44M | 51.47M | 161.28M | 198.94M |
Low Estimate | 37.73M | 41.11M | 145.30M | 176.20M |
Year ago Sales | 28.13M | 35.79M | 116.88M | 151.60M |
Year over Year Growth Est. | 44.65% | 28.37% | 29.70% | 26.23% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.01 | 0.06 | -0.72 | 0.37 |
# of Estimates | 4 | 4 | 3 | 4 |
Most Recent Consensus | -0.13 | -0.11 | -0.92 | 0.22 |
High Estimate | 0.25 | 0.32 | -0.33 | 0.94 |
Low Estimate | -0.21 | -0.28 | -1.01 | 0.08 |
Year ago EPS | -0.30 | 0.00 | -1.40 | -0.72 |
Year over Year Growth Est. | 103.33% | NA | 48.57% | 150.69% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 4 | 3 | 2 | 1 |
Up Last 60 Days | 4 | 3 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 3 |
Down Last 60 Days | 0 | 1 | 1 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.01 | 0.06 | -0.72 | 0.37 |
7 Days Ago | 0.01 | 0.06 | -0.72 | 0.37 |
30 Days Ago | -0.60 | -0.03 | -1.27 | 0.30 |
60 Days Ago | -0.60 | -0.03 | -1.27 | 0.30 |
90 Days Ago | -0.60 | -0.03 | -1.27 | 0.30 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.01 | 0.06 | -0.72 | 0.37 |
Zacks Consensus Estimate | 0.01 | 0.06 | -0.72 | 0.37 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.06 | -0.50 | 0.00 | -0.30 | NA |
Estimate | -0.37 | -0.30 | -0.30 | -0.70 | NA |
Difference | 0.31 | -0.20 | 0.30 | 0.40 | 0.20 |
Surprise | 83.78% | -66.67% | 100.00% | 57.14% | 43.56% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more